[BJCORP] QoQ Cumulative Quarter Result on 31-Jul-2009 [#1]

Stock
[BJCORP] BERJAYA CORPORATION BHD
Announcement Date
29-Sep-2009
Admission Sponsor
-
Sponsor
-
Financial Year
30-Apr-2010
Quarter
31-Jul-2009 [#1]
Profit Trend
QoQ- 174.74%
YoY- 20.9%
Quarter Report
Latest QR
Upcoming QR
BJCORP's Result
BJCORP's Financial Summary
View:
Show?
Cumulative Result
30/04/10 31/01/10 31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 CAGR
Revenue 6,757,534 4,890,870 3,230,078 1,612,065 6,339,012 4,828,720 3,097,771 68.44%
PBT 595,600 309,578 359,777 182,811 274,561 332,715 215,675 97.20%
Tax -205,528 -177,965 -130,037 -71,332 -165,465 -152,851 -100,244 61.60%
NP 390,072 131,613 229,740 111,479 109,096 179,864 115,431 125.69%
-
NP to SH 79,990 -64,478 91,728 39,901 -53,383 61,499 43,557 50.13%
-
Tax Rate 34.51% 57.49% 36.14% 39.02% 60.27% 45.94% 46.48% -
Total Cost 6,367,462 4,759,257 3,000,338 1,500,586 6,229,916 4,648,856 2,982,340 66.03%
-
Net Worth 5,693,546 5,633,147 5,851,890 5,890,651 5,870,739 6,057,078 6,109,060 -4.59%
Dividend
30/04/10 31/01/10 31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 CAGR
Div 40,732 - - - 129,090 89,765 89,788 -41.04%
Div Payout % 50.92% - - - 0.00% 145.96% 206.14% -
Equity
30/04/10 31/01/10 31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 CAGR
Net Worth 5,693,546 5,633,147 5,851,890 5,890,651 5,870,739 6,057,078 6,109,060 -4.59%
NOSH 4,073,219 4,015,359 3,952,911 3,930,769 3,853,455 3,819,813 3,820,789 4.36%
Ratio Analysis
30/04/10 31/01/10 31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 CAGR
NP Margin 5.77% 2.69% 7.11% 6.92% 1.72% 3.72% 3.73% -
ROE 1.40% -1.14% 1.57% 0.68% -0.91% 1.02% 0.71% -
Per Share
30/04/10 31/01/10 31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 CAGR
RPS 165.90 121.80 81.71 41.01 164.50 126.41 81.08 61.38%
EPS 1.96 -1.60 2.33 1.01 -1.39 1.61 1.14 43.65%
DPS 1.00 0.00 0.00 0.00 3.35 2.35 2.35 -43.51%
NAPS 1.3978 1.4029 1.4804 1.4986 1.5235 1.5857 1.5989 -8.59%
Adjusted Per Share Value based on latest NOSH - 3,930,769
30/04/10 31/01/10 31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 CAGR
RPS 113.33 82.03 54.17 27.04 106.31 80.98 51.95 68.44%
EPS 1.34 -1.08 1.54 0.67 -0.90 1.03 0.73 50.08%
DPS 0.68 0.00 0.00 0.00 2.17 1.51 1.51 -41.33%
NAPS 0.9549 0.9448 0.9814 0.9879 0.9846 1.0159 1.0246 -4.60%
Price Multiplier on Financial Quarter End Date
30/04/10 31/01/10 31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 CAGR
Date 30/04/10 29/01/10 30/10/09 31/07/09 30/04/09 30/01/09 31/10/08 -
Price 1.71 1.23 1.18 0.93 0.84 0.51 0.57 -
P/RPS 1.03 1.01 1.44 2.27 0.51 0.40 0.70 29.45%
P/EPS 87.08 -76.60 50.85 91.62 -60.64 31.68 50.00 44.90%
EY 1.15 -1.31 1.97 1.09 -1.65 3.16 2.00 -30.92%
DY 0.58 0.00 0.00 0.00 3.99 4.61 4.12 -73.03%
P/NAPS 1.22 0.88 0.80 0.62 0.55 0.32 0.36 126.12%
Price Multiplier on Announcement Date
30/04/10 31/01/10 31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 CAGR
Date 30/06/10 31/03/10 23/12/09 29/09/09 29/06/09 30/03/09 23/12/08 -
Price 1.27 1.75 1.21 0.98 0.93 0.52 0.57 -
P/RPS 0.77 1.44 1.48 2.39 0.57 0.41 0.70 6.57%
P/EPS 64.67 -108.98 52.14 96.54 -67.13 32.30 50.00 18.76%
EY 1.55 -0.92 1.92 1.04 -1.49 3.10 2.00 -15.66%
DY 0.79 0.00 0.00 0.00 3.60 4.52 4.12 -66.84%
P/NAPS 0.91 1.25 0.82 0.65 0.61 0.33 0.36 85.87%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment